Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-288370
Filing Date
2023-12-04
Accepted
2023-12-04 16:05:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d547914d424b5.htm 424B5 464782
2 GRAPHIC g547914dsp03.jpg GRAPHIC 4801
3 GRAPHIC g547914g1202051713761.jpg GRAPHIC 7923
  Complete submission text file 0001193125-23-288370.txt   483718
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-259224 | Film No.: 231462998
SIC: 2834 Pharmaceutical Preparations